Sign In
Buy HRTX
$0.496
-0.0012 (-0.241%)
At Close: Jul 31, 2026
Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most importan
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
12:00am, Monday, 01'st Jun 2020
Despite the FDA tied up with COVID-19-related activities, May turned out to be a positive month for biopharma companies from the perspective of drug approvals. Three new molecular...
Guggenheim Initiates Coverage On Heron Therapeutics with Buy Rating, Announces Price Target of $24
10:09am, Wednesday, 27'th May 2020Billionaire Jim Simons Pulls the Trigger on These 3 Healthcare Stocks
02:04pm, Wednesday, 20'th May 2020
Despite COVID-19's devastating impact, one legendary stock picker might have just cracked the market code. While the broader market tumbled, investing firm Renaissance Technologies and its founder Jim
Heron Therapeutics Announces Initiation of Phase 1b/2 Clinical Study of HTX-034 for the Treatment of Postoperative Pain
01:02pm, Monday, 18'th May 2020Heron Therapeutics Announces Initiation of Phase 1b/2 Clinical Study of HTX-034 for the Treatment of Postoperative Pain
01:00pm, Monday, 18'th May 2020
Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most importan
Sofinnova Ventures Inc Buys Alexion Pharmaceuticals Inc, Merck Inc, Align Technology Inc, Sells ...
12:00am, Wednesday, 13'th May 2020Searle & Co. Buys United Parcel Service Inc, Levi Strauss, SPDR Select Sector Fund - ...
12:00am, Tuesday, 12'th May 2020Pekin Singer Strauss Asset Management Buys Evercore Inc, Ituran Location and Control, TPI ...
12:00am, Monday, 11'th May 20203 Best Healthcare Stocks to Buy in May
12:00pm, Saturday, 09'th May 2020
AbbVie, Adverum Biotechnologies, and Heron Therapeutics could all be gearing up for a strong May. Here's why.
Earnings Update: Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Reported And Analysts Are Trimming Their Forecasts
02:04pm, Friday, 08'th May 2020
Heron Therapeutics, Inc. (NASDAQ:HRTX) just released its latest quarterly results and things are looking bullish. The...
U.S. RESEARCH ROUNDUP-Ashland Global Holdings, Lyft, Solaredge Technologies
07:34am, Thursday, 07'th May 2020
Wall Street securities analysts revised their ratings and price targets on
several U.S.-listed companies, including Ashland Global Holdings, Lyft and Solaredge
Technologies, on Thursday.
HIG
Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates
02:35pm, Wednesday, 06'th May 2020
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 9.52% and 25.36%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2020 and Highlights Recent Corporate Updates
01:00pm, Wednesday, 06'th May 2020
Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most importan
